Application of Mesoporous Silica Nanoparticle-Chitosan-Loaded BMP-2 in the Repair of Bone Defect in Chronic Osteomyelitis

Figure 4

BMSC activity evaluation. (a–c) Anti-Ki67 expression in control, PLGA, and Chi-MSN groups at 7th day. (d–f) Anti-Ki67 expression in control, PLGA, and Chi-MSN groups at 14th day.